Corrigendum to 'A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody': ESMO Open volume 9 issue 6 (2024) 103476

Saved in:
Bibliographic Details
Published inESMO open Vol. 9; no. 8; p. 103652
Main Authors Koyama, T, Kiyota, N, Boku, S, Imamura, Y, Shibata, N, Satake, H, Tanaka, K, Hayashi, H, Onoe, T, Asada, Y, Yamazaki, T, Nose, T, Ohata, S, Nagatani, Y, Kimbara, S, Funakoshi, Y, Teshima, M, Shinomiya, H, Minami, H
Format Journal Article
LanguageEnglish
Published Elsevier 01.08.2024
Subjects
Corrigendum
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Correction/Retraction-1
content type line 23
SourceType-Scholarly Journals-1
ISSN:2059-7029
2059-7029
DOI:10.1016/j.esmoop.2024.103652